Nowadays, Gleason score (GS), prostate-specific antigen (PSA) and clinical Tumor Node Metastasis (TNM) stages are considered as the most important factors that have significant impacts on the prognosis of PCa and the choices of treatments 4. The gene discussed is KLK3; the disease is neoplasm.